Skip to content

Clinical trials

Phase 4 Stroke trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 4 Country / region: Russia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20091
20121
20132
20151
20161
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pharmasoft2
Russian Academy of Medical Sciences2
Boehringer Ingelheim1
Burnasyan Federal Medical Biophysical Center1
Clinical Institute of the Brain, Russia1
Imperial College London1
Istituto Auxologico Italiano1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Russian Cardiology Research and Production Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke11
Ischemic Stroke3
Hypertension2
Angina Pectoris1
Atherosclerosis1
Brain Injuries, Traumatic1
Carotid Stenosis1
Cerebral Infarction1
Coronary Artery Disease1
Dementia1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.